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Introduction 
 
Lower urinary tract symptoms occur in 27% - 86% of patients with PD, the exact 
figure depending on the population studied and the assessment tool used to determine 
prevalence (Winge et al., 2006). Bladder dysfunction in PD has a negative impact on 
quality of life (McGrother et al., 2004) and represents a significant financial cost to the 
health care system (Milsom et al., 2014). “Storage” symptoms, including urinary 
frequency, nocturia, urgency and urge incontinence predominate (Araki and Kuno, 
2000), although “voiding” symptoms such as difficulty initiating voiding, straining to 
void and intermittent stream, also occur. An effective treatment for lower urinary tract 
symptoms would bring substantial benefit in terms of physical and psychosocial well-
being for sufferers. However, given the absence of a clear pathophysiological 
understanding of bladder dysfunction in PD, targeted pharmacological or surgical 
management is not yet available. 
 
A hallmark pathological feature of PD is degeneration of midbrain dopaminergic 
neurons in the substantia nigra pars compacta (SNc) and subsequently, reduced 
dopaminergic input to the striatum (Redgrave et al., 2010). According to early PD 
models, loss of dopaminergic striatal input produces motor dysfunction by promoting 
activity along the ‘indirect’ and suppressing activity along the ‘direct’ basal ganglia 
pathways, the net effect being overall suppression of movement due to an increase in 
the inhibitory influence of the GPi/SNr output complex on thalamo-cortical pathways 
(Albin et al., 1989). There is some evidence that dopamine depletion and basal ganglia 
dysfunction may contribute to the development of bladder symptoms in Parkinson’s 
disease. Two SPECT imaging studies of patients with Parkinson’s disease have 
demonstrated a relationship between bladder symptoms and depletion of dopaminergic 
neurons in the striatum (Sakakibara et al., 2001b; Winge et al., 2005). Moreover, 
intravenous administration of either a D1 receptor antagonist or a D2 receptor agonist, 
both of which increase inhibitory output from the GPi/SNr, reduces bladder capacity 
and increases the frequency of bladder contractions in the awake rat (Seki et al., 2001). 
There is also evidence to suggest that the GPi is involved in normal regulation of the 
micturition reflex in non-Parkinson’s disease subjects: pallidal neurons in awake-
immobilised cats display a triphasic activity pattern during micturition with increased 
firing rates just before the onset of a detrusor contraction (Porter, 1967) and 
neuroimaging studies in animals and humans confirm that activation of the globus 
pallidus occurs during urinary voiding (Nour et al., 2000; Tai et al., 2009; Shy et al., 
2014). Furthermore, electrical stimulation of the pallidum inhibits 
automatic/spontaneous bladder contractions in both anaesthetized cats (Lewin and 
Porter, 1965) and human subjects (Mordasini et al., 2014). However, despite evidence 
to support the role of the GPi in normal bladder function, no definite link has been 
established between pallidal dysfunction and the onset of urinary symptoms in 
PARKINSON’S DISEASE.  
 
The original ‘indirect-direct pathway’ theory described above is now viewed as an 
over-simplification of basal ganglia functional anatomy. The basal ganglia are more 
interconnected both intrinsically and with external subcortical structures than initially 
proposed (Redgrave et al., 2010) and some of these thalamostriatal-subcortical 
connections may be relevant to the pathophysiology of bladder dysfunction. The role 
of the brainstem-basal ganglia interactions in the onset of micturition disturbances in 
PD is important to consider because according to current scientific models of 
supraspinal micturition control, the major subcortical areas responsible for bladder 
function are located in the midbrain and pons, namely the periaqueductal grey area, the 
pontine micturition centre, and the pontine continence centre. 
 
The midbrain periaqueductal grey area (PAG) receives sensory information about 
bladder fullness via spinal cord afferents (Blok et al., 1995), transmits this information 
to the cortex, probably via the posterior thalamus, and also initiates the switch from 
‘storage’ to ‘voiding’ mode (Tai et al., 2009) when the bladder is full. Deep brain 
stimulation (DBS) of the subthalamic nucleus (STN) (Herzog et al, 2008) increases the 
degree of correlation between activity in the PAG and posterior thalamus during 
bladder filling in Parkinson’s disease patients and also normalizes bladder capacity, 
implying that deficits in sensorimotor processing involving the PAG and basal ganglia 
contribute to bladder dysfunction in Parkinson’s disease and can be corrected by 
neuromodulation at the STN.  
 
Further evidence suggests that the neural deficits underlying bladder dysfunction in 
Parkinson’s disease are not limited to the PAG and its basal ganglia connections. 
Abnormally reduced activation in parts of the brainstem (but not the PAG) during 
detrusor overactivity has been reported in Parkinson’s disease patients (Kitta et al., 
2006) and therefore microstructural changes involving pontine bladder control regions 
must also be considered as a possible contributory factor in the onset of lower urinary 
tract symptoms, either due to primary degeneration or altered input from abnormal 
basal ganglia projections. Two pontine areas described by Holstege and co-workers in 
the 1980s and 1990s (Holstege et al., 1986; Griffiths et al., 1990; Blok and Holstege, 
1994) and subsequently identified in numerous brain imaging studies of voiding 
(Fukuyama et al., 1996; Blok et al., 1997; Nour et al., 2000; Mehnert et al., 2008; 
Krhut et al., 2012;) are important for direct control of the micturition reflex via 
connections with the sacral parasympathetic nucleus of the spinal cord, which controls 
the bladder detrusor muscle (Blok and Holstege, 1997), and Onuf’s nucleus, located at 
the first and second sacral level, which contains somatic motor neurons innervating the 
pelvic floor and external urethral sphincter (Sato et al., 1978). The pontine ‘M-region’ 
in the dorsolateral pontine tegmentum (otherwise known as ‘Barrington’s nucleus’ or 
the ‘pontine micturition centre’) (Blok et al, 1995) projects monosynaptically to the 
sacral parasympathetic nucleus and also to the dorsal grey commissure (Loewy et al., 
1979; Holstege et al., 1986; Blok and Holstege, 1997). It directly excites bladder 
motorneurons of the sacral parasympathetic nucleus, leading to detrusor muscle 
contraction, and inhibits external urethral sphincter motorneurons via dorsal grey 
commissure GABA-ergic interneurons, which innervate Onuf’s nucleus (Blok and 
Holstege, 1999). Electrical stimulation of the ‘M-region’ leads to relaxation of the 
pelvic floor and the external urethral sphincter followed by bladder contraction 
(Holstege et al., 1986; Blok and Holstege, 1994); bilateral lesions produce urinary 
retention (Griffiths et al., 1990). A nearby region within the pontine tegmentum, 
ventral and lateral to the ‘M-region’, has excitatory projections to Onuf’s nucleus 
(Holstege et al., 1986) and is thought to be involved in maintaining sphincter tone 
during urine storage. This region is known as the pontine ‘L-region’. Electrical 
stimulation of the L-region in animals inhibits micturition and produces strong 
contraction of the external urethral sphincter (Kuru, 1965; Holstege et al., 1986) while 
bilateral lesions result in severe incontinence (Griffiths et al., 1990). Degenerative 
change and structural reorganisation in either of these bladder control regions could 
plausibly give rise to abnormal bladder and sphincter activity with associated 
symptoms of urinary frequency, urgency and incontinence. Measures of brain tissue 
microstructural integrity, such as FA and MD, can be obtained using diffusion MRI, 
which generates information in the form of quantitative diffusion maps based on 
diffusion properties of water. FA indicates the degree of alignment within white matter 
tracts while MD provides information about the size and membrane integrity of 
cellular structures. Altered FA and MD have been associated with tissue breakdown in 
a number of clinical imaging studies (Rovaris et al., 2002; Gallo et al., 2005); 
increased FA and/or reduced MD can signify cell swelling or increased cell density, 
while reduced FA and/or increased MD can represent demyelination and cell death. In 
order to investigate the role of the brainstem in the pathophysiology of bladder 
symptoms in Parkinson’s disease we used diffusion MRI to study the relationship 
between measures of brain grey and white matter structural integrity and lower urinary 
tract symptoms. We hypothesised that lower urinary tract dysfunction would be 
associated with structural changes in known bladder control regions of the brainstem, 
and that the extent of the change would correlate with the severity of bladder 
symptoms. We also hypothesized that structural connections would exist between 
abnormal brainstem areas and the basal ganglia, given the established involvement of 
the basal ganglia in both Parkinson’s disease and in bladder control (Porter 1967; Pazo 
1976; Sakakibara et al., 2001a; Winge et al., 2005; Herzog et al., 2006; Herzog et al., 
2008; Mordasini et al., 2014), and the fact that there are well described connections 
between the basal ganglia and various midbrain/brainstem regions (Erro et al., 1999; 
Martinez-Gonzalez et al., 2011). 
 
According to a recent case report, a patient experienced detrusor overactivity and 
symptoms of urinary urgency, frequency and urgency incontinence following deep 
brain stimulation of the PPN (Aviles-Olmos et al., 2011) a diffuse cell group known to 
undergo degeneration in Parkinson’s disease (Zweig et al., 1989; Hirsch et al., 1987) 
located in the rostral pontine/caudal mesencephalic tegmentum (Zrinzo et al., 2008; 
Alam et al., 2011) and functionally part of the mesencephalic locomotor region (Alam 
et al., 2011) and reticular formation (Ferraye et al., 2010). Although PPN DBS has 
been performed, with varying results, for the treatment of severe gait disturbance in PD 
(Pahapill and Lozano, 2000; Mazzone et al., 2005; Plaha and Gill, 2005), it has been 
suggested that PPN DBS can alter bladder function due to the anatomical proximity of 
the PPN and the pontine M-region (Aviles-Olmos et al., 2011; Blanco et al., 2013). To 
complement our study of the role of microstructural changes within the brainstem on 
bladder symptoms in Parkinson’s disease, we decided to select a group of patients with 
DBS electrodes implanted within the PPN region and investigate the effect of 
stimulation on bladder function. We planned to determine the anatomical relationship 
between the stimulating electrode and any areas of microstructural change that might 
be identified during our diffusion MRI analysis, in order to better understand the 
mechanism by which PPN DBS affects bladder function in Parkinson’s disease. 
 
 
Materials and Methods 
 
Subjects 
 
Two groups of patients were studied, an ‘MRI group’ and a ‘Urodynamics group’ (see 
table 1 for further details). There was no overlap between groups: i.e. subjects were 
either in the MRI group or the Urodynamics group but not both. 
 
MRI group 
 
17 patients with Parkinson’s disease who were due to have deep brain stimulation 
(DBS) for their movement disorder symptoms and had completed a pre-operative ‘non-
motor symptom questionnaire’ which included questions about bladder function, were 
included in this study. All patients underwent pre-operative magnetic resonance 
imaging (MRI) on a 1.5 Tesla Siemens scanner. During the MRI scan, diffusion-
weighted data was acquired using an echo planar imaging sequence (field of view = 
256 x 208 mm, matrix = 128 x 104, slice thickness 2 mm, in plane resolution = 2x2 
mm2, repetition time = 15 s, echo time = 106.2 ms, 32 directions, b value = 1000s/mm2, 
one image without diffusion weighting was obtained) (Owen et al., 2007). 
Furthermore, a high-resolution T1-weighted structural image (voxel size 1x1x1mm3) 
was acquired with a three-dimensional ‘FLASH’ sequence (TR = 12ms, TE = 5.6ms, 
flip angle = 19o, with elliptical sampling of k-space, giving a voxel size of 1 x 1 x 
1mm3 in 5.05 min).  
 
Urodynamics group 
 7 patients with DBS electrodes targeted to the PPN were recruited to undergo 
urodynamic testing, which took place in a hospital clinic in Oxford. None of these 
participants had been recruited to the MRI part of the study described above. The 
surgical procedure was carried out at the John Radcliffe Hospital for patients 1-6 and at 
the National Hospital for Neurology and Neurosurgery for patient 7. DBS electrodes 
were model 3387 (Medtronic) in Oxford patients and 3389 in the London patient - the 
four circumferential contacts are 1.27mm diameter and 1.5 mm in length and are 
1.5mm (3387) and 0.5 mm (3389) apart. Stimulation was either bipolar or monopolar 
in configuration. Details of the surgical procedure for electrode implantation have been 
reported elsewhere (Pereira et al., 2008;  Holl et al., 2010). For the Oxford patients, the 
electrode trajectory was based on visual identification of landmarks on a pre-operative 
MRI; target placement of the electrode was dorsolateral to the superior cerebellar 
peduncular decussation and medial to the medial lemniscus. An example of rostral and 
caudal electrode placement in the axial plane, along with a sagittal view of the 
electrode trajectory, can be seen in figure 1. For the London patient, electrode 
placement was guided by stereotactic proton density MRI sequences that were also 
used to confirm accurate lead placement. For further details refer to Avilés-Olmos et 
al., (2011). 
 
All patients gave consent for their information to be used for research purposes. All 
parts of this study were carried out in accordance with the Declaration of Helsinki and 
received approval from the Oxfordshire Research Ethics Committee B (study 
09/H0605/62). 
 
MRI group: Image analysis 
 
Images were analysed using the FMRIB Software Library (FSL) (Smith et al., 2004). 
 
Pre processing 
 
Each subject’s diffusion-weighted scans were individually inspected for gross 
distortions, corrected for head motion and eddy currents and brain extracted using BET 
(Smith, 2002a). FA, MD, axial diffusivity (L1), and radial diffusivity (L2 and L3) 
images were created by fitting a diffusion tensor model to the diffusion data using 
DTIFIT within the FMRIB diffusion toolbox (part of FSL). 
 
Tract-based spatial statistics (TBSS) 
 
Individual FA images were aligned to every other FA image, and the “most 
representative” result was used as a target image to which all the original FA images 
were non-linearly registered. The target image was then affine-aligned into MNI152 
standard space and each individual image transformed into 1x1x1mm MNI152 space 
by combining the nonlinear transform to the FA image with the affine transform from 
the target image to MNI152 space. Images were then averaged to create a mean FA 
image, which was thinned to create a mean FA skeleton 52. This FA skeleton 
represented the centres of all tracts common to the group.  
 
MD, axial and radial diffusivity images were subsequently processed in the same way 
as described above for FA. 
 
Voxel-Based Morphometry 
 
The T1-weighted data was analysed with FSL-VBM (Douaud et al., 2007), an 
optimised voxel-based morphometry protocol (Good et al., 2001; Smith et al., 2004) 
carried out with FSL tools (Smith et al., 2004). First, structural images were brain-
extracted and grey matter-segmented before being registered to the MNI152 standard 
space using non-linear registration (Andersson et al., 2007). The resulting images were 
averaged and flipped along the x-axis to create a left-right symmetric, study-specific 
grey matter template. Second, all native grey matter images were non-linearly 
registered to this study-specific template and “modulated” to correct for local 
expansion (or contraction) due to the non-linear component of the spatial 
transformation. The modulated grey matter images were then smoothed with an 
isotropic Gaussian kernel with a sigma of 3mm and voxelwise general linear model 
was applied using permutation-based non-parametric testing, correcting for multiple 
comparisons across space.  
 Assessment of Volume and Shape Differences of Subcortical Grey Matter 
Structures 
 
Grey matter segmentation was carried out on the T1-weighted data of each subject. 
Putamen, caudate and pallidum were segmented using FMRIB’s Integrated 
Registration and Segmentation Tool (FIRST) (Patenaude et al., 2011). In order to scale 
subcortical structure volume according to the head size of the individual patient, 
SIENAX was run for each subject (Smith et al., 2002b). SIENAX produced a 
volumetric scaling factor by which each subcortical region-of-interest volume was 
multiplied to provide an estimate of region-of-interest volume corrected for head size. 
Additionally, vertex analysis was performed on the putamen, caudate and pallidum, 
aiming to assess the correlation with bladder score on a per-vertex basis.  
 
Urodynamics group: Urodynamic procedure 
 
All patients within the urodynamics group had their Parkinson’s disease medications 
withheld for 12 hours prior to testing, with the exception of one patient (patient 7) who 
took a quarter of the normal dose of medication. Participants were asked to void urine 
in order to fully empty their bladder and urinalysis was performed to exclude a urinary 
tract infection. Participants then underwent bladder catheterisation with a dual lumen 
catheter (8Fr), and a rectal catheter (4.5Fr) was inserted to measure abdominal 
pressure. The bladder was infused with a sterile solution of isotonic saline at an 
average rate of 30ml min-1. During infusion of saline into the bladder, participants 
were asked to report when they first experienced the following sensations; 1. Initial 
sensation of bladder filling, 2. Initial desire to void, 3. Normal desire to void, 4. Strong 
desire to void, 5. Maximal capacity (point at which they could tolerate no further 
filling). When the patient reported reaching maximal capacity, the saline infusion was 
stopped immediately. If detrusor overactivity occurred, filling was stopped at this 
point, which was taken to be the maximum bladder capacity. The bladder was emptied 
via the catheter using a syringe and filling was repeated for a further 3 trials to give a 
total of 4 bladder fills. 
 
For each patient, bladder filling was carried out twice with PPN DBS turned ‘ON’ and 
twice with PPN DBS turned ‘OFF’. The ON/OFF order was pseudorandomised and 
allocated prior to the patient attending for the study. At least ten minutes was left 
between changing the stimulation and starting the next bladder infusion, to ensure that 
the effects of stimulation being ON or OFF had reached a steady state.  
 
Statistical analysis 
 
In order to correlate TBSS and grey matter segmentation results with bladder symptom 
severity, a “bladder score” was created based on the severity of four symptoms which 
are most prominent in PD (based on combined gender estimates) according to 
Sakaibara et al’s study in 2001 (Sakakibara et al., 2001a), namely urinary frequency, 
nocturia, urinary urgency and urge incontinence. Severity scores were generated for 
each of these four variables based on a 1-4 scale, where a score of ‘1’ represented no 
symptoms at all and ‘4’ represented a significant problem with the symptom in 
question. Scores were summed to give a total bladder score out of 16, which was then 
used in subsequent analysis.  
 
MRI group  
 
TBSS correlations 
 
Right and left brainstem masks were produced using the Juelich Histological Atlas, 
thresholded at 50%, binarized and applied to the mean TBSS skeleton mask.  
 
Correlations between bladder score and DTI metrics were determined using 
permutation-based non-parametric testing applied to voxel-wise general linear model, 
carried out using the whole brain white matter skeleton and the brainstem mask, with 
age as a covariate of no interest. Results were considered significant for p < 0.05, after 
correction for multiple comparisons (family wise error, FWE) within each region of 
interest, using the threshold-free cluster enhancement (TFCE) approach (Smith and 
Nichols, 2009). Pearson’s correlation between bladder score and subcortical 
segmentation volumes corrected for head size was also tested using IBM SPSS 
Statistics for Mac (version 20). Results were visualised using TBSS fill. This is an 
algorithm that ‘thickens’ the skeletonised results by filling them out to occupy the local 
tracts seen in the mean FA map.  
 
Subcortical grey matter segmentation 
 
Pearson’s Product Moment Correlation between subcortical grey matter volume 
corrected for head size and bladder score was calculated using IBM SPSS Statistics for 
Mac (version 20). Results of partial correlations corrected for age were considered 
significant for p < 0.05 after applying Bonferroni correction for multiple comparisons.  
 
Post-hoc Probabilistic Tractography from ‘Significant’ TBSS results 
 
We ran probabilistic tractography for all subjects in MNI space from the significant 
MD results, thresholded each individual tractography output at 10% of the maximum 
value, binarised the thresholded output, and then averaged these for all subjects to 
create left and right group masks. 
 
Urodynamics group 
 
ON/OFF Deep Brain Stimulation and Urodynamics 
 
The mean bladder capacity with DBS ON and OFF was calculated for each subject and 
a Wilcoxon Signed Rank Test was used to assess for a statistically significant 
difference between the mean bladder capacity with DBS ON and DBS OFF.  
 
To identify the area of maximal effective stimulation for each patient, which we will 
refer to from now as the ‘stimulation site’, a mask of the midpoint between the two 
active contacts in the case of bipolar stimulation, or the active contact itself in the case 
of monopolar stimulation, was made on the post-operative CT scan (or post-op MRI 
scan for patient 7) which showed the position of the DBS electrodes. The post-
operative scan was registered to the pre-operative T1-weighted scan using FMRIB’s 
Linear Image Registration Tool (FLIRT) (Jenkinson and Smith, 2001; Jenkinson et al., 
2002), and the pre-operative T1-weighted scan was then non-linearly registered to the 
MNI152 brain. Similarly, the transformation used to register the T1-weighted scan to 
MNI space was used to register the masks of the stimulation site. The stimulation site 
for each subject was then plotted along with the significant areas of microstructural 
change identified by the TBSS analysis (see results). Subjects were grouped according 
to the proximity of their stimulation site and the regions of microstructural change. 
Subjects whose stimulation site overlapped with or fell within 1mm of the TBSS fill 
regions in which MD significantly correlated with bladder score, were classified as 
‘subgroup 1’ and subjects whose stimulation site was further away from this region 
were classified as ‘subgroup 2’. The effect of DBS on bladder function was re-
analysed for each subgroup, again using a Wilcoxon test. 
 
Long-term bladder symptom follow-up 
 
Two patients from the urodynamic part of the study completed bladder symptom 
questionnaires pre-operatively and six months post-operatively in order for us to gain 
preliminary information about whether the urodynamic response to PPN DBS 
predicted clinical response over the long term.  
 
Results 
 
MRI group 
 
Clinical information 
 
There were 13 male and 4 female subjects within the MRI group and the mean age at 
the time of MRI scan was 67.34 ± 5.97 years (range 54-75). The mean bladder score 
was 8.12 ± 3.38 (range 4-16). There was no significant correlation between bladder 
score and age, or bladder score and pre-operative Unified PD Rating Scale (UPDRS) 
values. Further clinical information is given in table 2. 
 
Tract-based spatial statistics (TBSS) 
 
TBSS using the entire white matter skeleton did not show any significant correlation 
between bladder scores and DTI measures of white matter microstructural integrity. 
However, using the intersection of the right and left brainstem masks with the skeleton 
as regions-of-interest, there were regions in which MD (left and right brainstem), axial 
diffusivity (left brainstem) and radial diffusivity (right brainstem) correlated with 
bladder score (Figures 2A and 2C). There was also a separate but nearby area in the 
left brainstem where MD and radial diffusivity were inversely correlated with bladder 
score (Figure 2B).  
 
Anatomical location of pontine bladder areas  
 
In order to determine the proximity between brainstem areas in which MD correlated 
with bladder score and known pontine bladder regions, we referred to Blok et al’s 1997 
PET study, which identifies neural activations thought to represent activation of the 
pontine M-region and pontine L-region based on comparisons between neural activity 
during ‘urine withholding’, ‘micturition’ and ‘empty bladder’ states. The voxel of 
maximal activation assumed to be the pontine ‘L-region’ or ‘continence centre’ was 
converted from Talairach to MNI space using GingerALE (http://brainmap.org/) 
(Eickhoff et al., 2009; Eickhoff et al., 2012) and overlaid onto the images showing 
areas where MD correlated significantly with bladder symptom severity (figure 3A). 
As the region identified in Blok’s study was on the right side only, whereas the pontine 
L-region is expected to be a bilateral area based on animal studies (Griffiths et al., 
1990), we calculated the left sided equivalent by inverting the co-ordinate in the X 
dimension. A similar conversion from Blok’s 1997 study was used to generate an 
approximate location of the pontine M-region.  
 
As shown in figure 3A, Blok’s ‘L-region’ overlapped with the left-sided regions in 
which MD correlated with bladder symptom severity. There was no overlap between 
the location of the pontine M-region and the areas where MD correlated with bladder 
score (figure 3B). 
 
Volumes and shape of subcortical grey matter structures 
 
One subject was excluded from this part of the analysis due to poor automated 
segmentation. Analysis of the remaining 16 subjects revealed a significant negative 
correlation (R = -0.654, p < 0.05) between left pallidal volume (corrected for head 
size) and bladder score, which survived Bonferroni correction for multiple 
comparisons (Figure 4A). Vertex-wise analysis of the pallidum, caudate and putamen 
did not reveal any significant correlation with bladder score on a per-vertex basis. 
 
Tractography from significant TBSS results 
 
Probabilistic tractography using the areas where MD significantly correlated with 
bladder score as seed regions produced group maps for the left and the right 
hemisphere. Tracts on the right passed through the right brainstem and right 
cerebellum. Tracts on the left passed to the left brainstem, left cerebellum, left 
pallidum and left precentral gyrus (figure 4B).  
 
Urodynamic study 
 
Clinical information: Urodynamic group 
 
All 7 patients who underwent the urodynamic testing were male. 6 had DBS electrodes 
targeted bilaterally to the pedunculopontine nucleus. One patient (patient 3) also had 
bilateral STN DBS electrodes which were switched off throughout testing. One patient 
(patient 1) had a right-sided PPN electrode only. Information about patient 
demographics and stimulation parameters is given in table 3. 
 
Whole group analysis 
 
Comparison of mean bladder capacity OFF vs ON PPN DBS revealed no significant 
effect on bladder capacity of PPN stimulation, although there was a trend towards an 
increased bladder capacity with stimulation ON (OFF DBS: 137 mls (range 39-254) vs 
ON DBS: 188 mls (range 40-441). The mean maximal bladder capacity ON and OFF 
DBS for each patient is given in table 3. 
 
Subgroup analysis based on location of stimulation site  
 
The stimulation site for each patient was located in relation to the brainstem regions 
identified in the TBSS analysis (figure 5A). 
 
For two patients (subgroup 2), the stimulation site was distant from the regions of 
microstructural change and there was no significant effect of DBS on bladder capacity 
(OFF DBS: 176 mls (range 52-300); ON DBS: 159 mls (range 40-279). 
 
For five patients (subgroup 1), the stimulation site closely approximated the regions of 
brainstem microstructural change identified in the TBSS analysis (figure 2). Of these, 
four patients (patients 3-6) had stimulation sites that directly overlapped with the 
regions of microstructural change presented with TBSS fill, and one patient (patient 7) 
was included within this group because his stimulation site was within 1mm of the 
regions in which MD correlated with bladder score. Furthermore, on a less 
conservative estimate of stimulation site, there was found to be overlap with his 
stimulation site and the regions of microstructural change. In all five patients within 
subgroup 1, the overlap between stimulation site and microstructural change occurred 
on the left but not the right, although in one patient the right-sided electrode came 
close to the significant regions. Statistical analysis showed that PPN DBS significantly 
increased mean maximal bladder capacity in subgroup 1 patients (OFF DBS: 131 mls 
(range 39-230); ON DBS: 199 mls (range 103-440), p < 0.05, Wilcoxon test) (figure 
5B). 
 
Relationship between gait and bladder symptom improvements 
 
The follow-up data on gait and freezing episodes shows no clear relationship between 
gait/freezing improvement and bladder capacity improvement with stimulation (table 
3). Both patients in subgroup 2 (no improvement in bladder capacity with DBS) had 
improved gait and freezing symptoms post-operatively. The subgroup 1 patients had a 
mixed response to DBS: three patients showed improvements in both gait and freezing 
measures post-operatively, one patient experienced no change in either gait or freezing 
and one patient had worsening of his gait symptoms but no increase in the amount or 
severity of freezing. We note that, the patient whose gait symptoms worsened at 6-
month follow-up (patient 5), was the patient with the most dramatic increase in bladder 
capacity with DBS. 
 
Long-term follow-up of 2 DBS patients 
 
A patient from subgroup 1 (improvement in bladder capacity with DBS) and a patient 
from subgroup 2 (no improvement in bladder capacity with DBS) completed bladder 
symptom questionnaires pre-operatively and six months post-operatively. For the 
patient from subgroup 1, bladder symptoms improved 6 months after surgery (bladder 
score improved from 12 to 8). For the patient from subgroup 2, bladder symptoms 
worsened (bladder score worsened from 8 to 10) (see Figure 5C). 
 
Discussion  
 
To investigate the neural basis of lower urinary tract symptoms in Parkinson’s disease, 
we studied the association between microstructural anatomical changes within the 
brainstem and the severity of bladder symptoms in a group of Parkinson’s disease 
patients. Given the importance of the pons in the control of the micturition reflex, we 
hypothesised that lower urinary tract dysfunction in Parkinson’s disease would be 
related to structural changes within pontine bladder control regions. In support of our 
hypothesis, we found areas bilaterally within the brainstem in which MD, a measure 
derived from diffusion-weighted MRI data, correlated significantly with bladder 
symptom severity. Increased MD can signify cell death, and reduced MD can occur in 
areas of cell swelling or increased cell density. Our analysis indicated that there were 
bilateral areas in which MD correlated positively with bladder symptom severity, and 
an adjacent left-sided region where MD was negatively correlated with bladder 
symptom severity. One interpretation of this finding is that the two areas of significant 
but opposite correlation between MD and bladder symptom severity could represent 
populations of two different neuronal cell types responding with different structural 
changes to a single pathological process, with either the primary process or the 
resultant changes having a detrimental effect on bladder function.  
 
In order to understand the structural changes revealed by our analysis more fully, we 
compared the location of the areas in which microstructural change correlated with 
bladder dysfunction with the predicted location of known pontine bladder control 
areas, namely the pontine ‘M-region’ (pontine micturition centre) and the pontine ‘L-
region’ (pontine continence centre). Co-ordinates provided by a seminal PET study on 
bladder control by Blok et al., 1997 were used to plot the location of the M-region and 
L-region alongside our data. We found that the pontine L-region, but not the M-region, 
was in close proximity to the areas we had identified. This suggests that structural 
changes in the pontine L-region in Parkinson’s disease could be associated with the 
development of lower urinary tract symptoms. The pontine L-region is thought to 
facilitate continence by maintaining contraction of the external urethral sphincter and 
pelvic floor during bladder storage. Bilateral lesions give rise to severe incontinence 
(Griffiths et al., 1990), and so it is highly plausible that incomplete destruction of this 
area, as may be indicated by our results, would give rise to milder symptoms of 
frequency, nocturia, urgency and urge incontinence; the symptoms assessed by our 
bladder score. 
 
Abnormal basal ganglia function is a central pathophysiological feature of Parkinson’s 
disease (Albin et al., 1989), and based on this understanding, along with evidence from 
previous studies that deep brain stimulation at the subthalamic nucleus, part of the 
basal ganglia, can improve bladder function in Parkinson’s disease (Finazzi-Agro et 
al., 2003; Herzog et al., 2006; Herzog et al., 2008), we assessed the relationship 
between structural changes in the basal ganglia and lower urinary tract symptoms. We 
identified volume reduction within the left pallidum that correlated with bladder 
symptom severity and furthermore, we found that tracts seeded from the brainstem 
areas where MD correlated significantly with bladder symptom severity projected to 
the left pallidum, raising the possibility that the microstructural changes within the two 
areas could be related. Previous experimental evidence has shown that pallidal activity 
is modulated by bladder filling and urinary voiding (Porter, 1967) and that electrical 
stimulation of the globus pallidus reduces the frequency of spontaneous detrusor 
muscle contractions (Lewin and Porter, 1965; Pazo, 1976; Mordasini et al., 2014). 
Single unit recording studies in the 1970s identified similar triphasic patterns of 
neuronal activity in the globus pallidus and the anterior brainstem during urinary 
voiding, implying a functional connection between these regions in the co-ordination 
of micturition (Porter et al., 1971). Finally, surgical lesioning of the GPi in a patient 
with Parkinson’s disease was shown to produce degeneration of pallido-tegmental 
neurons and selective degeneration of a 2mm cell region dorsolateral to the decussation 
of the superior cerebellar peduncle thought to be in the region of the PPN but “largely 
dorsal and medial to the majority of large, intensely AchE-positive” neurons which 
make up the cholinergic sub-division of the PPN (Rye et al., 1996). Overall, this 
evidence supports the view that a functional unit comprised of the GPi and parts of the 
brainstem are involved in co-ordinating urinary voiding, and that there are structural 
connections between the two regions that are susceptible to neurodegeneration. Our 
present structural findings support this possibility. We suggest that we may have 
described Parkinson’s disease -related degeneration within a single functional pathway 
responsible for lower urinary tract control, which involves the globus pallidus and the 
pontine L-region.  
 
Implications for future management of lower urinary tract symptoms 
 
Having identified changes within this putative brainstem-basal ganglia continence 
pathway, we investigated whether deep brain stimulation targeting the system at the 
level of the brainstem could improve lower urinary tract symptoms. Filling cystometry 
in seven patients with deep brain stimulation electrodes implanted in the region of the 
PPN revealed that stimulation increased bladder capacity in a subgroup of patients 
whose stimulation sites co-incided with left-sided brainstem regions where MD 
correlated with bladder symptom severity, implying that stimulation restored function 
in these areas. Furthermore, long-term follow up of a patient from the subgroup whose 
bladder capacity improved with DBS showed that he had improved lower urinary tract 
symptoms 6 months post-operatively. These follow-up findings suggest that the 
urodynamic improvement in bladder capacity may predict clinical improvements in 
continence, although an adequately powered prospective clinical study will be needed 
to evaluate this properly.  
 
Anatomical relationship between effective stimulation sites and the 
pedunculopontine nucleus 
 
Although all patients recruited to this study had received unilateral or bilateral deep 
brain stimulation of the PPN region, the anatomical distribution of stimulation sites 
was fairly wide, and most sites were caudal and slightly ventral to the defined 
boundaries of the PPN reported by one group (Zrinzo et al., 2008; Zrinzo et al., 2011). 
There exists a degree of variability in surgical methods for identifying and targeting of 
the PPN (Plaha and Gill, 2005; Pereira et al., 2008; Ferraye et al., 2010; Zrinzo et al., 
2011); also, as a reticular structure, it can be argued that its boundaries are difficult to 
accurately define (Ferraye et al., 2010). The majority of patients experienced 
improvements in gait and freezing symptoms post-operatively, suggesting that the 
neuromodulation was effective in targeting the mesencephalic locomotor area. 
However, as there was no obvious direct relationship between gait/freezing 
improvement and bladder response to DBS, the single optimal stimulation site for 
gait/freezing is probably different to the ideal target for bladder symptom control. 
Moreover, as there is likely to be controversy about whether all of the electrodes were 
placed within the PPN proper, we cannot draw any conclusions about the effect of 
strictly anatomically defined “PPN DBS” on bladder capacity. Rather, the electrodes in 
this particular group of subjects happened to be placed in such a way as to have an 
effect on areas of the brainstem where microstructural metrics correlated with bladder 
function; areas that are highly likely to be linked to the pontine L-region. Finally, we 
acknowledge that the brainstem is a highly pulsatile structure and that therefore MRI 
scans of this region are susceptible to motion artefact, which could have influenced the 
results presented here, particularly as pulse gating was not used during the acquisition. 
It is clear that further investigation, using optimised scan protocols, is needed to 
examine whether there is an “ideal target” for DBS for lower urinary tract symptoms in 
Parkinson’s disease and whether it a clinically useful intervention in terms of quality of 
life, and to determine the relationship between this area and the optimal stimulation 
site that may improve gait. Further MRI studies should be carried out using pulse 
gating an  
 
Left-sided predominance of effects 
 
An interesting feature of this study is the fact that the effective stimulation sites were 
all on the left side of the brainstem. Based on original animal experiments, the pontine 
L-region is expected to be bilateral (Griffiths et al., 1990), and in functional imaging 
experiments, midline, right-sided and left-sided pontine sites associated with urinary 
control have all been identified (Fukuyama et al., 1996; Blok et al., 1997; Nour et al., 
2000; Mehnert et al., 2008; Krhut et al., 2012). Our relatively small sample size 
prevents us from drawing any definitive conclusions. However, questions about the 
side of effective stimulation and the side of degenerative changes in Parkinson’s 
disease giving rise to bladder dysfunction should be directly addressed in future 
studies.  
 
Worsening of bladder symptoms 
 
We note that a previous report has been published regarding a patient with PPN DBS 
who developed incontinence following electrode implantation (Aviles-Olmos et al., 
2011). The two patients in the present study whose stimulation sites did not overlap 
with the regions where MD correlated with bladder function (subgroup 2) each 
experienced reduced bladder capacity with stimulation turned ON, and one of these 
patients also reported a deterioration in bladder function at 6-months follow-up. These 
2 patients had electrodes implanted at opposite ends of the rostro-caudal axis range 
occupied by the 7 patient electrodes, which means that there does not appear to be a 
simple anatomical explanation for the effect. However, it is important to recognise the 
risk of causing bladder symptoms when implanting electrodes into the brainstem. A 
greater awareness of the functional anatomy of this region and the way in which it 
changes in Parkinson’s disease would improve our ability to avoid these side-effects 
following DBS. 
 
Summary 
 
Our data suggests a possible basal ganglia-brainstem pathway involving the GPi and 
the pontine L-region whose degeneration appears to contribute to lower urinary tract 
symptoms in Parkinson’s disease. This raises the possibility of DBS modulation of 
bladder function at the level of the brainstem.  
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Supplementary Materials 
 
Bladder questions 
 
Patients were asked to select how much each of the following problems affected them: 
A. Frequency: going to the toilet very often 
B. Nocturia: getting up at night to pass urine 
C. Urgency: a strong and difficult to control desire to pass urine 
D. Urge incontinence: urinary leakage accompanied by strong desire to pass urine 
 
Options were: (1) Never (2) A little (3) Moderately (4) A lot 
 
This was taken from a more comprehensive non-motor symptom questionnaire 
administered to all patients prior to DBS surgery. These particular questions are drawn 
from the King’s Health Quality of Life Questionnaire (Kelleher et al., 1997). 
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